India’s Advinus Therapeutics Launches U.S. Office To Build Clinical Development Knowledge And Client Base
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's biggest pure drug discovery company Advinus Therapeutics, part of the giant steel-to-tea Tata conglomerate, announced it is launching a U.S. operation to build its client base and be closer to cutting-edge medical developments